Singapore's Biobot Surgical raises $15.5m in funding led by ClavystBio

Singapore's Biobot Surgical raises $15.5m in funding led by ClavystBio

Normal cells of human connective tissue in culture at a magnification of 500x. Photo by National Cancer Institute on Unsplash

Mars W. Mosqueda Jr.

29 June, 2026

Edited by: Joymitra Rai

Biobot Surgical ClavystBio Zig Ventures

Printed by Unregistered user on Fri, 14 Aug 2026 12:48:43 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Singapore’s BIOBOT Surgical secures S$10m, ClavystBio joins cap table

Data Vantage: Biobot Surgical, EnableX, and LeadSquared in focus

Read more from Singapore

Beyond the Buyout: India’s hospital gold rush has a valuation problem

SE Asia Deal Review: Startup funding falls 84% in July after June’s surge